Frequency of acute worsening events in fibrotic pulmonary sarcoidosis patients

Respiratory Medicine

Volumn 107, Issue 12, 2013, Pages 2009-2013

  Baughman, Robert P ^a   Lower, Elyse E ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Bronchiectasis; Infliximab; Prednisone; Sarcoidosis

Indexed keywords

AZATHIOPRINE; LEFLUNOMIDE; METHOTREXATE; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; AGE; AGED; ARTICLE; BRONCHIECTASIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FIBROSIS; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SMOKING;

BRONCHIECTASIS; INFLIXIMAB; PREDNISONE; SARCOIDOSIS;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRONCHIECTASIS; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PULMONARY FIBROSIS; RECURRENCE; RESPIRATORY SYSTEM AGENTS; RETROSPECTIVE STUDIES; SARCOIDOSIS, PULMONARY; VITAL CAPACITY; YOUNG ADULT;

EID: 84890310850     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.10.014     Document Type: Article

References (25)

1. E. Panselinas, and M.A. Judson Acute pulmonary exacerbations of sarcoidosis Chest 142 2012 827 836
2. G. Rizzato, L. Montemurro, and P. Colombo The late follow-up of chronic sarcoid patients previously treated with corticosteroids Sarcoidosis 15 1998 52 58
3. J.E. Gottlieb, H.L. Israel, R.M. Steiner, J. Triolo, and H. Patrick Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy Chest 111 1997 623 631
4. B.P. McKinzie, W.M. Bullington, J.E. Mazur, and M.A. Judson Efficacy of short-course, low-dose corticosteroid therapy for acute pulmonary sarcoidosis exacerbations Am J Med Sci 339 2010 1 4
5. C.J. Johns, and T.M. Michele The clinical management of sarcoidosis: a 50-year experience at the Johns Hopkins hospital Medicine 78 1999 65 111
6. L.M. Young, N. Good, D. Milne, I. Zeng, J. Kolbe, and M.L. Wilsher The prevalence and predictors of airway hyper-responsiveness in sarcoidosis Respirology 17 2012 653 659
7. J.L. Hankinson, J.R. Odencrantz, and K.B. Fedan Spirometric reference values from a sample of the general U.S. population Am J Respir Crit Care Med 159 1999 179 187
8. M.A. Judson, G.E. Gilbert, J.K. Rodgers, C.F. Greer, and S.I. Schabel The utility of the chest radiograph in diagnosing exacerbations of pulmonary sarcoidosis Respirology 13 2008 97 102
9. O.P. Sharma, and R. Johnson Airway obstruction in sarcoidosis. A study of 123 nonsmoking black American patients with sarcoidosis Chest 94 1988 343 346
10. R.P. Baughman, A.S. Teirstein, M.A. Judson, M.D. Rossman, H.J. Yeager, E.A. Bresnitz, L. DePalo, G. Hunninghake, M.C. Iannuzzi, and C.J. Johns Clinical characteristics of patients in a case control study of sarcoidosis Am J Respir Crit Care Med 164 2001 1885 1889
11. A. Nardi, P.Y. Brillet, P. Letoumelin, F. Girard, M. Brauner, Y. Uzunhan, J.M. Naccache, D. Valeyre, and H. Nunes Stage IV sarcoidosis: comparison of survival with the general population and causes of death Eur Respir J 38 2011 1368 1373
12. N.R. Anthonisen, J. Manfreda, C.P. Warren, E.S. Hershfield, G.K. Harding, and N.A. Nelson Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease Ann Intern Med 106 1987 196 204
13. B.R. Celli, and W. MacNee Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper Eur Respir J 23 2004 932 946
14. E.S. Wan, D.L. DeMeo, C.P. Hersh, S.D. Shapiro, R.A. Rosiello, S.R. Sama, A.L. Fuhlbrigge, M.G. Foreman, and E.K. Silverman Clinical predictors of frequent exacerbations in subjects with severe chronic obstructive pulmonary disease (COPD) Respir Med 105 2011 588 594
15. P.R. Burgel, P. Nesme-Meyer, P. Chanez, D. Caillaud, P. Carre, T. Perez, and N. Roche Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects Chest 135 2009 975 982
16. M. Miravitlles, T. Guerrero, C. Mayordomo, L. Sanchez-Agudo, F. Nicolau, and J.L. Segu Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group Respiration 67 2000 495 501
17. I.S. Patel, I. Vlahos, T.M. Wilkinson, S.J. Lloyd-Owen, G.C. Donaldson, M. Wilks, R.H. Reznek, and J.A. Wedzicha Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease Am J Respir Crit Care Med 170 2004 400 407
18. A.S. Hennebicque, H. Nunes, P.Y. Brillet, H. Moulahi, D. Valeyre, and M.W. Brauner CT findings in severe thoracic sarcoidosis Eur Radiol 15 2005 23 30
19. M. Paslawski, W. Krupski, and J. Zlomaniec Fibrotic changes in high-resolution computed tomography in patients with sarcoidosis Ann Univ Mariae Curie Sklodowska Med 59 2004 303 307
20. T.A. Pena, A.O. Soubani, and L. Samavati Aspergillus lung disease in patients with sarcoidosis: a case series and review of the literature Lung 189 2011 167 172
21. D.E. Furst The risk of infections with biologic therapies for rheumatoid arthritis Semin Arthritis Rheum 39 2008 327 346
22. S. Kroesen, A.F. Widmer, A. Tyndall, and P. Hasler Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy Rheumatology (Oxford) 42 2003 617 621
23. L. Dirven, T.W. Huizinga, and C.F. Allaart Risk factors for reported influenza and influenza-like symptoms in patients with rheumatoid arthritis Scand J Rheumatol 41 2012 359 365
24. M.A. Lane, J.R. McDonald, A.L. Zeringue, L. Caplan, J.R. Curtis, P. Ranganathan, and S.A. Eisen TNF-alpha antagonist use and risk of hospitalization for infection in a national cohort of veterans with rheumatoid arthritis Medicine (Baltimore) 90 2011 139 145
25. R.P. Baughman, R. Shipley, S. Desai, M. Drent, M.A. Judson, U. Costabel, R.M. du Bois, M. Kavuru, R. Schlenker-Herceg, and S. Flavin Changes in chest roentgenogram of sarcoidosis patients during a clinical trial of infliximab therapy: comparison of different methods of evaluation Chest 136 2009 526 535